Objective: To determine which antiepileptic drugs pregnant women receive by trimester.
Methods: This retrospective cohort study using the IBM Watson Health MarketScan Research Databases evaluated which antiepileptic drugs pregnant women with epilepsy received by trimester. Women with aged 15-54 years with a history of seizure disorder who underwent a delivery hospitalization between 2008 and 2017 were included in the analysis.
Background: Anti-seizure medications (ASMs) are used to treat conditions such as epilepsy and bipolar disorder. Some of these drugs are associated with an increased risk of congenital malformations and adverse developmental outcomes.
Objectives: To examine trends in use of ASMs among pregnant women in the Netherlands according to medication safety profile.
J Matern Fetal Neonatal Med
December 2022